Patents Assigned to VelosBio Inc.
  • NOVEL ROR1 ANTIBODY IMMUNOCONJUGATES
    Publication number: 20230293712
    Abstract: Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-binding fragment thereof and an exatecan moiety or an analog thereof. These immunoconjugates are useful for treating ROR1-expressing cancers.
    Type: Application
    Filed: July 8, 2021
    Publication date: September 21, 2023
    Applicant: Velosbio Inc.
    Inventors: Brian Lannutti, Katti Jessen, Xin Guo, Mira Ko, Jeffry D. Watkins, Stephanie Louise Johnson, Colin Martin McKee
  • ANTI-ROR1 ANTIBODIES AND COMPOSITIONS
    Publication number: 20230021388
    Abstract: This invention relates to anti-ROR1 antibodies and methods of using them in treating diseases and conditions related to ROR1 activity, e.g., cancer.
    Type: Application
    Filed: February 5, 2021
    Publication date: January 26, 2023
    Applicant: VelosBio Inc.
    Inventors: Jeffry D. WATKINS, Thanh-Trang VO, J. Monty WATKINS
  • ANTI-ROR1 / ANTI-CD3 BISPECIFIC BINDING MOLECULES
    Publication number: 20220227866
    Abstract: This invention relates to bispecific binding molecules that bind to ROR1 and CD3, and methods of using them to treat diseases and conditions such as cancer.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 21, 2022
    Applicant: VelosBio Inc.
    Inventors: Jeffry D. Watkins, Katti Jessen, Mira Ko, Brian Lannutti, Thanh-Trang Vo, J. Monty Watkins
  • CANCER TREATMENT WITH ROR1 ANTIBODY IMMUNOCONJUGATES
    Publication number: 20220152214
    Abstract: Provided herein are methods for treating a cancer patient with immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety.
    Type: Application
    Filed: February 1, 2020
    Publication date: May 19, 2022
    Applicant: VelosBio Inc.
    Inventors: Langdon Miller, Brian Lannutti, Katti Jessen
  • ROR1 ANTIBODY IMMUNOCONJUGATES
    Publication number: 20220133901
    Abstract: Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR1 expressing cancers.
    Type: Application
    Filed: November 11, 2021
    Publication date: May 5, 2022
    Applicant: VelosBio Inc.
    Inventors: Brian Lannutti, Katti Jessen, Thanh-Trang Vo, Jeffry Dean Watkins
  • ROR1 Antibody Immunoconjugates
    Publication number: 20200030454
    Abstract: Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR1 expressing cancers.
    Type: Application
    Filed: April 5, 2019
    Publication date: January 30, 2020
    Applicant: VelosBio Inc.
    Inventors: Brian Lannutti, Katti Jessen, Thanh-Trang Vo, Jeffry Dean Watkins
  • ROR1 antibody immunoconjugates
    Patent number: 10335496
    Abstract: Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR1 expressing cancers.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: July 2, 2019
    Assignee: VelosBio Inc.
    Inventors: Brian Lannutti, Katti Jessen, Thanh-Trang Vo, Jeffry Dean Watkins
  • ROR1 Antibody Immunoconjugates
    Publication number: 20180369406
    Abstract: Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are useful for treating ROR1 expressing cancers.
    Type: Application
    Filed: July 5, 2018
    Publication date: December 27, 2018
    Applicant: VelosBio Inc.
    Inventors: Brian Lannutti, Katti Jessen, Thanh-Trang Vo, Jeffry Dean Watkins